Soligenix's Unattributed VC - II Round

Soligenix raised a round of funding on March 12, 2004.

Soligenix is a clinical stage biopharmaceutical company developing products to treat serious gastrointestinal diseases where there remains an unmet medical need, as well as developing several biodefen…

Articles about Soligenix's Unattributed VC - II Round: